MOLZYM

molzym-logo

Molzym was founded as a privately owned enterprise in Bremen, North-West Germany, in 2003. Ever since, Molzym has been committed to the development of innovative solutions to serve biological research and diagnosis of infectious diseases. Our developmental efforts are particularly focused on new processes enabling and facilitating the molecular diagnosis of infectious diseases caused by bacteria and fungi. Meanwhile, more than 50 high quality products are available for molecular microbial analysis by PCR-, hybridization- and NGS-based methods in 30 countries worldwide.

#People #Website #More

MOLZYM

Industry:
B2B Health Diagnostics

Founded:
2003-01-01

Address:
Bremen, Bremen, Germany

Country:
Germany

Website Url:
http://www.molzym.com

Status:
Active

Contact:
+49 (0) 421 / 69 61 62 0

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Apache Global Site Tag US Privacy User Signal Mechanism



Current Advisors List

michael-lustig_image

Michael Lustig Product Management Diagnostics @ Molzym
Board_member

Current Employees Featured

michael-lorenz_image

Michael Lorenz
Michael Lorenz CEO @ Molzym
CEO

gabriel-tirouflet_image

Gabriel Tirouflet
Gabriel Tirouflet Chief Executive Officer @ Molzym
Chief Executive Officer
2019-12-01

Official Site Inspections

http://www.molzym.com Semrush global rank: 4.89 M Semrush visits lastest month: 1.78 K

  • Host name: www85.your-server.de
  • IP address: 213.133.104.85
  • Location: Nuremberg Germany
  • Latitude: 49.4475
  • Longitude: 11.0683
  • Timezone: Europe/Berlin
  • Postal: 90409

Loading ...

More informations about "Molzym"

Molzym

Molzym is a manufacturer of innovative products supplying new solutions in molecular diagnostics and biology with emphasis on pre-analytical and analytical tools. Among the products are โ€ฆSee details»

Molzym - Crunchbase Company Profile & Funding

Molzym was founded as a privately owned enterprise in Bremen, North-West Germany, in 2003. Ever since, Molzym has been committed to the development of innovative solutions to serve โ€ฆSee details»

Meet us - Molzym

Mar 22, 2024ย ยท Molzym is a manufacturer of innovative products supplying new solutions in molecular diagnostics and biology with emphasis on pre-analytical and analytical tools. Among โ€ฆSee details»

Molzym GmbH & Co. KG | LinkedIn - LinkedIn Deutschland

Molzym is a developer and manufacturer of innovative products for molecular microbiology and microbial pathogen diagnostics. Products range from pre-analytical kits for the enrichment and...See details»

Molzym | VentureRadar

Molzym has developed a broad portfolio of patented technologies and reagents for pathogen-DNA enrichment, isolation and detection, including PCR and NGS applications. If specific solutions โ€ฆSee details»

Molzym GmbH & Co. KG - Bremen, Germany - bionity.com

Molzym has developed a broad portfolio of patented technologies and reagents for pathogen-DNA enrichment, isolation and detection, including PCR and NGS applications. If specific solutions โ€ฆSee details»

Molzym GmbH & Co. KG - SelectScience

Molzym is a developer and manufacturer of innovative products for molecular microbiology research and routine microbial pathogen diagnostics. The product portfolio comprises of pre โ€ฆSee details»

Molzym Company Profile 2024: Valuation, Investors, Acquisition

Information on acquisition, funding, investors, and executives for Molzym. Use the PitchBook Platform to explore the full profile.See details»

Molzym GmbH & Co. KG - Life-Sciences-Europe.com

Aug 1, 2003ย ยท LinkedIn: https://www.linkedin.com/company/molzym-gmbh-&-co-kg. Molzymโ€™s flagship technology, MolYsisโ„ข, allows for pure microbial DNA extraction to enhance the direct โ€ฆSee details»

Molzym GmbH & Co. KG - pharmaceutical Technology

Molzym manufactures ultra-clean and highly active amplification reagents and kits for microbial nucleic acid extraction from a variety of specimens. In particular, reagents and consumables โ€ฆSee details»

About - Molzym

Molzym is a manufacturer of innovative products supplying new solutions in molecular diagnostics and biology with emphasis on pre-analytical and analytical tools. Among the products are โ€ฆSee details»

Molzym - 2022 - Wiley Analytical Science

Molzym was founded as a privately owned enterprise in Bremen, North-West Germany, in 2003. Ever since, Molzym has been committed to the development of innovative solutions to serve โ€ฆSee details»

Molzym - FAPIC

Molzym is a partner SME in FAPIC that will contribute especially with its nucleic acid isolation expertise in bacterial and fungal diagnostic products and market exploitation. Molzym has a โ€ฆSee details»

Molzym - Goffin Molecular Technologies

Pioneering Molecular Diagnostics for Precision Healthcare. Molzym, based in Bremen, Germany, stands at the forefront of molecular diagnostics, revolutionizing healthcare with its innovative โ€ฆSee details»

Molzym announces double-digit million EUR capital increase

Jul 13, 2022ย ยท Molzym, a global leader of microbial DNA isolation - dedicated to broad-range molecular diagnostic solutions and NGS applications, based in Bremen, Germany - is proud to โ€ฆSee details»

Technology - molzym.com

Molzym is a manufacturer of innovative products supplying new solutions in molecular diagnostics and biology with emphasis on pre-analytical and analytical tools. Among the products are โ€ฆSee details»

3 questions to Molzym: โ€œOur goal is to ... - Potsdam Science Park

Molzym offers innovative products for isolating and identifying the DNA of an organism, or, more specifically, a pathogen that is, of a pathogen. In this context, we develop new methods that โ€ฆSee details»

Discover Molzym โ€” Molecular Diagnostic Solutions - YouTube

Sep 27, 2023ย ยท From CE IVD-marked broad-range molecular diagnostic kits, host DNA depletion technology, MolYsisโ„ข, to ultra-clean PCR reagents and assays, Molzym is one of the leading โ€ฆSee details»

Molzym announces FDA Breakthrough Device Designation for its โ€ฆ

May 12, 2021ย ยท MMDx utilizes specific enrichment and extraction processes of microbial DNA directly from samples, DNA-free reagents and consumables (including Universal 16S and 18S โ€ฆSee details»